Yokoyama Takeshi, Mizuguchi Mineyuki, Ostermann Andreas, Kusaka Katsuhiro, Niimura Nobuo, Schrader Tabias E, Tanaka Ichiro
Faculty of Pharmaceutical Sciences, University of Toyama , 2630 Sugitani, Toyama 930-0914, Japan.
Heinz Maier-Leibnitz Zentrum (MLZ), Technische Universität München , Lichtenbergstrasse 1, 85748 Garching, Germany.
J Med Chem. 2015 Sep 24;58(18):7549-56. doi: 10.1021/acs.jmedchem.5b01147. Epub 2015 Sep 4.
Farnesyl pyrophosphate synthase (FPPS) catalyzes the condensation of isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate to FPP and is known to be a molecular target of osteoporosis drugs, such as risedronate (RIS), which is a nitrogen-containing bisphosphonate. The protonation states and hydration structure of RIS bound to FPPS were determined by neutron protein crystallography, which allows direct visualization of hydrogens and deuteriums. The structure analysis revealed that the phosphate groups of RIS were fully deprotonated with the abnormally decreased pKa, and that the roles of E93 and D264 consisted of canceling the extra negative charges upon the binding of ligands. Collectively, our neutron structures provided insights into the physicochemical properties during the bisphosphonate binding event.
法尼基焦磷酸合酶(FPPS)催化异戊烯基焦磷酸(IPP)和二甲基烯丙基焦磷酸缩合生成FPP,并且已知其是骨质疏松症药物(如利塞膦酸盐(RIS),一种含氮双膦酸盐)的分子靶点。通过中子蛋白质晶体学确定了与FPPS结合的RIS的质子化状态和水合结构,该技术能够直接观察氢和氘。结构分析表明,RIS的磷酸基团完全去质子化,且其pKa异常降低,并且E93和D264的作用是在配体结合时抵消额外的负电荷。总的来说,我们的中子结构为双膦酸盐结合过程中的物理化学性质提供了见解。